Work

Prevalence and clinical implications of NRAS mutations in childhood AML: a report from the Children's Oncology Group

Year: 2011

Type: article

Source: Leukemia

DOI: 10.1038/leu.2011.31

Authors: J N Berman, R B Gerbing, T A Alonzo, P A Ho, K Miller, C Hurwitz, N A Heerema, B Hirsch, S C Raimondi, B Lange, J L Franklin, A Gamis, S Meshinchi

Institutions: Dalhousie University, Izaak Walton Killam Health Centre, Children's Oncology Group, University of Southern California, University of Washington, Fred Hutch Cancer Center, Reata Pharmaceuticals (United States), The Ohio State University, University of Minnesota, Masonic Cancer Center, St. Jude Children's Research Hospital, Children's Hospital of Philadelphia, University of Pennsylvania, Amgen (United States), Children's Mercy Hospital

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: G2135062745, G2901481919, G301932103, G312129226, Support for Human Specimen Banking in NCI-Sponsored Clinical Trials-(CGB), G421865639, G997771125

OpenAlex ID: W2056575941

FWCI: 1.885

Cites: 21

Cited by: 36

Related to: 10